Economic costs of obsessive-compulsive disorder
- PMID: 10141765
Economic costs of obsessive-compulsive disorder
Abstract
Obsessive-compulsive disorder (OCD), classified as a severe mental illness by the National Advisory Mental Health Council, affects 2.1% of the population annually, as shown by the Epidemiological Catchment Area surveys. This study, using the human capital approach, estimated the direct and indirect costs of OCD. The total costs of OCD were estimated to be $8.4 billion in 1990, 5.7% of the estimated $147.8 billion cost of all mental illness, and 18.0% of the costs of all anxiety disorders, estimated to be $46.6 billion. The indirect costs of OCD, reflecting lost productivity of individuals suffering from or dying from the disorder, were estimated at $6.2 billion.
Similar articles
-
Economic costs of anxiety disorders.Anxiety. 1996;2(4):167-72. doi: 10.1002/(SICI)1522-7154(1996)2:4<167::AID-ANXI2>3.0.CO;2-L. Anxiety. 1996. PMID: 9160618
-
Economic costs of diabetes in the U.S. In 2007.Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Diabetes Care. 2008. PMID: 18308683 Review.
-
Health economics and cost implications of anxiety and other mental disorders in the United States.Br J Psychiatry Suppl. 1998;(34):4-9. Br J Psychiatry Suppl. 1998. PMID: 9829010
-
Costs of occupational injuries and illnesses in California.Prev Med. 2001 May;32(5):393-406. doi: 10.1006/pmed.2001.0841. Prev Med. 2001. PMID: 11330988
-
The costs of schizophrenia.J Clin Psychiatry. 2007;68 Suppl 14:4-7. J Clin Psychiatry. 2007. PMID: 18284271 Review.
Cited by
-
Association of granulocyte macrophage colony-stimulating factor and interleukin-17 levels with obsessive-compulsive disorder: a case-control study findings.Sci Rep. 2023 Nov 3;13(1):18976. doi: 10.1038/s41598-023-46401-8. Sci Rep. 2023. PMID: 37923827 Free PMC article.
-
Complexity changes in functional state dynamics suggest focal connectivity reductions.Front Hum Neurosci. 2022 Sep 23;16:958706. doi: 10.3389/fnhum.2022.958706. eCollection 2022. Front Hum Neurosci. 2022. PMID: 36211126 Free PMC article.
-
Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial.BMC Pharmacol Toxicol. 2022 Sep 27;23(1):73. doi: 10.1186/s40360-022-00610-5. BMC Pharmacol Toxicol. 2022. PMID: 36167636 Free PMC article. Clinical Trial.
-
Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial.BMC Psychiatry. 2022 Jan 12;22(1):34. doi: 10.1186/s12888-021-03642-z. BMC Psychiatry. 2022. PMID: 35022014 Free PMC article. Clinical Trial.
-
The cost of obsessive-compulsive disorder (OCD) in China: a multi-center cross-sectional survey based on hospitals.Gen Psychiatr. 2021 Dec 6;34(6):e100632. doi: 10.1136/gpsych-2021-100632. eCollection 2021. Gen Psychiatr. 2021. PMID: 34950853 Free PMC article.